
Porton Pharma Solutions Ltd. — Investor Relations & Filings
Porton Pharma Solutions Ltd. is a global contract development and manufacturing organization (CDMO) providing end-to-end solutions for the pharmaceutical and biotechnology sectors. The company specializes in the development and manufacturing of small molecule APIs, intermediates, and drug products, while expanding its capabilities into biologics and cell and gene therapies. Its service portfolio encompasses process research and development, analytical services, pilot-scale production, and large-scale commercial manufacturing. Porton operates a network of R&D centers and manufacturing facilities designed to meet international regulatory standards, including those of the FDA and EMA. By leveraging an integrated technology platform, the company supports clients throughout the entire drug lifecycle, from preclinical development to commercialization, focusing on operational excellence and supply chain security.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第六届董事会第二次临时会议决议公告 | 2025-07-22 | Chinese | |
| 关于实际控制人部分股份质押、质押展期及解除质押的公告 | 2025-07-22 | Chinese | |
| 关于增聘高级管理人员的公告 | 2025-07-22 | Chinese | |
| 2025年半年度业绩预告 | 2025-07-10 | Chinese | |
| 关于实际控制人部分股份质押及解除质押的公告 | 2025-06-19 | Chinese | |
| 关于全资三级子公司通过欧盟QP审计的公告 | 2025-06-19 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 36839039 | 第六届董事会第二次临时会议决议公告 | 2025-07-22 | Chinese | ||
| 36838986 | 关于实际控制人部分股份质押、质押展期及解除质押的公告 | 2025-07-22 | Chinese | ||
| 36838980 | 关于增聘高级管理人员的公告 | 2025-07-22 | Chinese | ||
| 36838972 | 2025年半年度业绩预告 | 2025-07-10 | Chinese | ||
| 36838953 | 关于实际控制人部分股份质押及解除质押的公告 | 2025-06-19 | Chinese | ||
| 36838946 | 关于全资三级子公司通过欧盟QP审计的公告 | 2025-06-19 | Chinese | ||
| 36838937 | 关于全资子公司通过欧盟QP审计的公告 | 2025-06-18 | Chinese | ||
| 36838929 | 第六届监事会第一次临时会议决议公告 | 2025-05-08 | Chinese | ||
| 36838917 | 关于续聘高级管理人员及证券事务代表的公告 | 2025-05-08 | Chinese | ||
| 36838903 | 第六届董事会第一次临时会议决议公告 | 2025-05-08 | Chinese | ||
| 36838894 | 关于职工代表大会选举产生第六届监事会职工代表监事的公告 | 2025-04-29 | Chinese | ||
| 36838885 | 2024年年度股东会决议公告 | 2025-04-28 | Chinese | ||
| 36838875 | 北京市万商天勤律师事务所关于重庆博腾制药科技股份有限公司2024年年度股东会的法律意见书 | 2025-04-28 | Chinese | ||
| 36838867 | 北京市万商天勤律师事务所关于重庆博腾制药科技股份有限公司作废部分2022年限制性股票激励计划已授予但尚未归属的限制性股票的法律意见书 | 2025-04-24 | Chinese | ||
| 36838860 | 关于作废部分2022年限制性股票激励计划已授予但尚未归属的限制性股票的公告 | 2025-04-24 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Porton Pharma Solutions Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55356/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55356 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55356 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55356 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55356}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Porton Pharma Solutions Ltd. (id: 55356)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.